MEDITECH Expanse EHR system boosts Willis Knighton patient care
This strategic move has replaced three separate EHRs, offering care coordination across the organisation's ambulatory and acute care facilities.
Willis Knighton's integration is set to deliver improved healthcare outcomes and operational efficiencies.
Willis Knighton Health Information Technology senior vice president and chief information officer Mark Galea said: 'One of the concerns we've heard from patients is that they have to repeat information when visiting different providers.
'This integration responds to that concern and supports access to the electronic records for all Willis Knighton locations and providers.'
Patients within the Willis Knighton network are now experiencing the benefits of a shared EHR platform, which eliminates the need for redundant tests and provides access to a single patient portal for viewing test results and visit notes.
Clinicians also gain from having all patient data consolidated in one location, lessening administrative tasks and saving time.
In the process of this implementation, the clinics have worked together to standardise order sets and documentation templates.
This collaboration has facilitated a swift deployment of the system across all clinic locations.
The MEDITECH Expanse platform also offers the flexibility to tailor workflows, meeting the specific requirements of various medical specialists.
Willis Knighton has further incorporated Expanse Oncology at its Cancer Center.
This addition is designed to automate practice management and enhance the delivery of care for cancer patients, particularly by sharing real-time information among the care teams.
MEDITECH executive vice president and chief operating officer Helen Waters said: "This achievement underscores their unwavering commitment to exceptional patient care and lays a strong foundation for continued innovation and growth.'
In alignment with its commitment to patient-centred care, Willis Knighton has also introduced MEDITECH Expanse at its rehabilitation centre, progressive care centre, and skilled nursing facility.
This expansion follows the recent decision by Harbor Regional Health to continue its long-standing partnership with MEDITECH by adopting the Expanse EHR system.
"MEDITECH Expanse EHR system boosts Willis Knighton patient care" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Vitamin Supplements Market Size to Capture USD 113.93 Billion by 2034, Driven by Growing Health Awareness, Innovative Product Forms and AI Integration
According to Towards FnB, the global vitamin supplements market size is evaluated at USD 59.92 billion in 2025 and is predicted to hit around USD 113.93 billion by 2034, growing at a CAGR of 7.4% during the forecast period from 2025 to 2034. Ottawa, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global vitamin supplements market size stood at USD 55.79 billion in 2024 and is expected to grow steadily form USD 59.92 billion in 2025 to around USD 113.93 billion by 2034, expanding at a CAGR of 7.4% from 2025 to 2034, according to study published by Towards FnB, a sister firm of Precedence Research. The market has experienced significant growth in recent years, largely due to the rapid prevalence of diseases affecting a substantial portion of the population. An increasing health-conscious attitude among people of different age groups, along with rising awareness about health and nutrition, are also growth factors for the market. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making. Access the Full Study Instantly | Download Sample Pages of the Report Now@ Market Overview The vitamin supplements market is observing a huge hike in the recent period due to the developing health-conscious attitude among the population of different age groups. Vitamin supplements help consumers to complete their nutritional requirements easily, which might be missed from the regular diet. Such supplements are focused on providing the nutrition required in an ideal quantity, making it easy for an individual to measure the quantities as per their health. Innovation in the supplements market has made it easy for kids to consume vitamin supplements. They are available in gummy form and in different flavors to make it easy for kids to maintain their nutritional requirements. Adults also enjoy such a form of supplements and do not miss out on their gummies, helping them to maintain their nutritional requirements and keeping deficiencies at bay. It helps consumers to avoid various health issues caused by vitamin deficiency, such as skin and hair issues, overall health, cell repair and growth, and immune function. Consumer preferences are shifting, particularly among millennials and Gen Z, who are prioritizing natural and plant-based supplements. A significant portion of these consumers is leaning toward gummy supplements, as they are perceived as more enjoyable and easier to incorporate into daily routines. Additionally, vegan vitamin supplements are seeing increased demand due to the rise in plant-based diets. Key Highlights of the Vitamin Supplements Market By region, North America dominated the vitamin supplements market in 2024, whereas the Asia Pacific is expected to grow in the foreseeable period due to the growing population's health management and the need to keep the aging population healthy. By form, the tablet segment led the market for vitamin supplements in 2024, whereas the gummies segment is expected to grow in the foreseen period due to its convenience factor and availability of flavors, making it easy for kids to consume. By type, the multivitamin segment led the vitamin supplements market in 2024, whereas the vitamin D segment is expected to grow due to the rising prevalence of cardiovascular diseases among the population of different age groups. By distribution channel, the offline segment led the vitamin supplements market in 2024, whereas the online segment is expected to grow in the foreseen period due to the rise of online platforms, due to its multiple benefits, and providing a knowledge factor. New Trends in the Vitamin Supplements Market High demand for recovery supplements has been observed in the recent period, as such supplements help in quick recovery after exercising. They are made up of ingredients like electrolytes for hydration, protein for muscle repair, and various other essential nutrients that help replenish energy and lower soreness after a heavy training session. Collagen supplements are another highly demanded supplement in the market as they support hair, nail, and skin health. Hence, the beauty trends help the sale of the product, further helping the growth of the vitamin supplements market. Magnesium is another vitamin supplement highly demanded in the market these days, as it aids in natural sleep. It helps to aid rest for the body, helpful for muscle repair. The vitamin supplements market is also experiencing growth due to government initiatives, NGO initiatives, and educating people about the importance of vitamin supplements. How Has AI Impacted the Vitamin Supplements Market? Artificial intelligence (AI) is reshaping the vitamin supplements market by driving innovation, personalization, and efficiency across the value chain. One of the most notable benefits is the ability of AI to analyze massive datasets on consumer health profiles, genetic information, and lifestyle patterns to create personalized supplement recommendations. This has fueled the rise of customized vitamin packs and subscription models tailored to individual nutritional needs. AI also accelerates research and development by simulating ingredient interactions, predicting efficacy, and identifying emerging health trends, enabling faster launches of new and targeted formulations. In manufacturing, AI-powered quality control systems ensure consistency and safety by detecting impurities or variations in raw materials and finished supplements. Marketing strategies have become more precise as AI-driven tools leverage customer behavior analytics and social media sentiment to design targeted campaigns that resonate with different age groups and health-conscious consumers. Recent Developments in the Vitamin Supplements Market In April 2025, Vitamin Shoppe launched its GLP-1-inspired line of supplements to aid natural weight loss. The line consists of meal replacement powder, fiber supplements, and a multivitamin supplement. (Source- In July 2025, Vegamour launched its vegan haircare and hair growth supplements. The supplements combine vitamins, minerals, and adaptogens essential for hair growth and strengthen the hair locks. (Source- View Full Market Intelligence@ Market Dynamics What are Major Drivers for Vitamin Supplements Market? Multiple health factors have helped the growth of the vitamin supplements market in the recent period. Growing awareness of health and overall fitness, and a health-conscious attitude among people, have helped the growth of the vitamin supplements market. The increasing prevalence of different types of diseases also helps the growth of the market in the form of high demand for vitamin supplements. Growing consciousness for hair, skin, and nail health is also leading to demand for collagen supplements, further boosting the growth of the vitamin supplements market. A busy lifestyle leading to improper nutrition and an incomplete diet is also helping the growth of the market, as supplements help to recover the nutritional deficiencies. What Factors Create Limitations for Vitamin Supplements Market? High demand for different types of vitamin supplements by different age groups is one of the major challenges observed in the growth of the vitamin supplements market. If the supply is inadequate as per the demand, then the population may miss out on their supplements, lowering the market's growth. Supply chain disruptions due to multiple reasons are also a major reason affecting the growth of the market. What is the Largest Potential Factor for Vitamin Supplements Market? Innovation in vitamin supplements is helping the growth of the vitamin supplements market, as consumers are highly demanding such supplements. Vitamins are essential for overall health and are also an essential part of maintaining beauty features such as hair, skin, and nail health. Hence, such factors also help the growth of the market. Availability of vitamin supplements in plant-based forms for vegans and plant-diet followers is also helping the growth of the market. Gummies and flavored vitamin supplements are also aiding the growth of the market in the foreseeable period. Vitamin Supplements Market Regional Analysis North America dominated the Vitamin Supplements Market in 2024 North America led the vitamin supplements market in 2024 due to rising awareness about health and nutrition, and overall well-being in the region. Consumers in the region are conscious about the overall well-being and importance of vitamin supplements for the same. High demand for vitamin D, vitamin C, multivitamins, zinc, and collagen supplements has also helped the growth of the vitamin supplements market in the region. High demand for organic and plant-based supplements has also helped the growth of the market. Canada has a huge contribution to the growth of the market in the region, with high demand for vitamin D supplements for its multiple benefits and overall health benefits too. Asia Pacific Is expected to Grow with the Highest CAGR in the Forecast Period Asia Pacific is expected to grow with the highest CAGR in the forecast period due to the rising aging population in the region. Vitamin supplements are helpful for maintaining overall health and completing the nutritional requirements that might not be fulfilled with a basic diet. Hence, such supplements are essential for growing kids and aged adults to complete their nutritional requirements. Countries like China, Japan, and South Korea have the highest contribution to the growth of the market due to the rising aging population of the region. Vitamin Supplements Market Report Scope Report Attribute Key Statistics Base Year 2024 Forecast Period 2025 to 2034 Growth Rate from 2025 to 2034 CAGR of 7.4% Market Size in 2024 USD 55.79 Billion Market Size in 2025 USD 59.92 Billion Market Size by 2034 USD 113.93 Billion Dominated Region North America Fastest Growing Region Asia Pacific Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Have Questions? Let's Talk—Schedule a Meeting with Our Insights Team: Vitamin Supplements Market Segmental Analysis Form Analysis Why Did the Tablet Segment Lead the Vitamin Supplements Market in 2024? The tablet segment led the vitamin supplements market in 2024 due to its convenience factor and multiple health benefits for the human body. Tablets are easy to consume, have a longer shelf life, and are also easy to carry while travelling, so that one doesn't miss out on essential nutrients while being outdoors. Tablets available in different coatings, as per the preference of each individual, also help the growth of the vitamin supplements market. Gummies and slow-release tablets for their full-day effect also help the growth of the market. The Gummies Segment is Expected to Grow in the Forecast Period Gummy vitamins are expected to grow in the foreseeable period due to their multiple health benefits available in different flavor options. Due to the innovation and availability in chewy texture and different flavors, kids easily consume such nutritional gummies. It helps them to maintain their nutritional requirements. Adults can also consume vitamin gummies to complete their nutritional requirements and avoid deficiencies, further fueling the growth of the vitamin supplements market. It is, though, advised to keep a check on the consumption of vitamins such as calcium, iron, vitamin D, and vitamin A, as their high consumption is harmful to health. Type Analysis Why Did the Multivitamin Segment Lead the Vitamin Supplements Market in 2024? The multivitamin segment led the vitamin supplements market in 2024 due to its importance and high consumption globally, as it helps in aiding overall health. The multivitamins are essential for people of different age groups and their overall well-being. Hence, their high consumption at the global level helped the growth of the market in 2024. Vitamin C, vitamin D, and zinc top the list of essential nutrients and hence are highly demanded, further fueling the growth of the market. The Vitamin D Segment Is Observed to Grow in the Foreseen Period High demand for vitamin D these days, for its multiple health benefits, is helping the growth of the vitamin supplements market in the foreseeable future. Vitamin D, along with calcium, helps build bone health and keep the bones healthy. The nutrient also helps to maintain immunity, along with maintaining muscles and brain cells. Distribution Channel Analysis How Did the Offline Segment Lead the Vitamin Supplements Market in 2024? The offline segment led the vitamin supplements market in 2024 due to its convenience factor, allowing consumers to shop for the required supplements easily and refill them as well. The segment also helped the growth of the market by providing different types of supplements along with beauty supplements and treatments, alongside further fueling the beauty trends and market growth. The Online Segment is Expected to Grow in the Expected Timeframe The online segment is observed to grow in the foreseen period due to its high demand from the convenience and knowledge point of view. The E-pharmacy option is extremely beneficial for seniors, the disabled, and consumers living in remote areas who might face issues in visiting pharmacies physically. Online pharmacies also provide discounts on certain occasions, making the supplement shopping more economical. Hence, the segment is observed to fuel the growth of the vitamin supplements market in the foreseeable period. Feel Free to Get in Touch with Us for Orders or Any Questions at: sales@ Additional Topics Worth Exploring: Infant Nutrition Market: The global infant nutrition market size is set for steady growth increasing from USD 60.13 billion in 2025 to USD 144.11 billion by 2034, with a CAGR of 10.2% during the forecast period from 2025 to 2034. Infant Formula Ingredient Market: The global infant formula ingredient market size increasing from USD 25.01 billion in 2025 to USD 57.07 billion by 2034, driven by a CAGR of 9.60% during the forecast period from 2025 to 2034. Food Leavening Agent Market: The global food leavening agent market size is projected to witness strong growth from USD 7.64 billion in 2025 to USD 11.06 billion by 2034, reflecting a CAGR of 4.2% over the forecast period from 2025 to 2034. Food Texture Market: The global food texture market size is increasing from USD 16.67 billion in 2025 to USD 27.22 billion by 2034, driven by a CAGR of 5.6% during the forecast period from 2025 to 2034. Food Intolerance Products Market: The global food intolerance products market size is projected to grow from USD 97.47 billion in 2025 to USD 302.26 billion by 2034, reflecting a CAGR of 13.40% over the forecast period from 2025 to 2034. Superfoods Market: The global superfoods market size is expected to grow from USD 201.17 billion in 2025 to USD 288.82 billion by 2034, at a CAGR of 4.10% during the forecast period from 2025 to 2034. Probiotics Animal Feed Market: The global probiotics animal feed market size was estimated at USD 4.99 billion in 2024 and is expected to rise from USD 5.44 billion in 2025 to nearly reaching USD 11.72 billion by 2034, growing at a CAGR of 8.86% during the forecast period from 2025 to 2034. Feed Phosphate Market: The global feed phosphate market size is rising from USD 2.82 billion in 2025 to USD 4.75 billion by 2034. This projected expansion reflects a CAGR of 5.96% throughout the forecast period from 2025 to 2034. Textured Vegetable Protein Market: The global textured vegetable protein market size is expected to grow from USD 1.92 billion in 2025 to USD 3.48 billion by 2034, at a CAGR of 6.97% over the forecast period from 2025 to 2034. Organic Pet Food Market: The global organic pet food market size is projected to expand from USD 2.54 billion in 2025 to USD 4.41 billion by 2034, growing at a CAGR of 6.34% during the forecast period from 2025 to 2034. Key Players in Vitamin Supplements Market Nordic Naturals NOW Foods Abbott Amway Doctor's Best Inc Biophar Lifesciences Pvt Ltd Ritual Garden of Life Nestle Health Sciences Pharmavite Thorne Aesthetic Nutrition Arlak Biotech Pvt Ltd Gianful HealthAid Jarrow Formulas Segments Covered in the Report By Type Multivitamin Vitamin A Vitamin B Vitamin C Vitamin D Vitamin E Vitamin K By Form Powder Tablets Capsules Softgels Gummies Others By Distribution Channel Offline Pharmacies & Drugstores Hypermarkets/Supermarkets Others Online By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Thank you for exploring our insights. For more targeted information, customized chapter-wise sections and region-specific editions such as North America, Europe, or Asia Pacific are also available upon request. For Detailed Pricing and Tailored Market Report Options, Click Here: Feel Free to Get in Touch with Us for Orders or Any Questions at: sales@ Unlock expert insights, custom research, and premium support with the Towards FnB Annual Membership. For USD 495/month (billed annually), get full access to exclusive F&B market data and personalized guidance. It's your strategic edge in the food and beverage industry: About Us Towards FnB is a global consulting firm specializing in the food and beverage industry, providing innovative solutions and expert guidance to elevate businesses. With an in-depth understanding of the dynamic F&B sector, we deliver customized market analysis and strategic insights. Our team of seasoned professionals is committed to empowering clients with the knowledge needed to make informed decisions, ensuring they stay ahead of market trends. Partner with us as we redefine success in the rapidly evolving food and beverage landscape, and together, we'll navigate this transformative journey. Web: Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Chemical and Materials| Nova One Advisor | Food Beverage Strategies | For Latest Update Follow Us: LinkedIn | Medium| TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
By Jonathan Stempel (Reuters) -A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs. In a Tuesday decision, Chief Judge Mitchell Goldberg in Philadelphia federal court tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act. He added a $4.87 million civil fine. Goldberg rejected CVS' request to pay less, saying that while CVS Caremark was liable for only two years of overbilling, evidence at trial "made clear that the fraud was financially motivated, not the result of some innocent or mistaken belief." CVS, based in Woonsocket, Rhode Island, said on Wednesday it plans to appeal. Last month, a Manhattan federal judge ordered CVS' Omnicare unit to pay $948.8 million in a separate whistleblower lawsuit alleging fraudulent billing. CVS plans to appeal that judgment. Goldberg presided in March over a non-jury trial in the whistleblower case brought by Sarah Behnke, a former head actuary for Medicare Part D at Aetna. She accused CVS Caremark of having caused health insurers such as Aetna to submit inflated claims since 2010 to the Centers for Medicare and Medicaid Services (CMS), while pharmacies such as Rite Aid and Walgreens were paid less. CVS argued that the original $95 million in damages was substantial, and punitive damages should be limited to $95 million. But the judge said CVS Caremark's fraud not only financially harmed the government, but diminished public confidence in it. "CMS relies on companies like Caremark to truthfully and accurately report Part D drug prices," he wrote. "Caremark's conduct broke CMS's trust, and as a result, the public's trust in CMS." Behnke sued in 2014. CVS bought Aetna four years later. The False Claims Act lets whistleblowers sue on behalf of the government and share in recoveries, typically 15% to 30%. The case is US ex rel Behnke v CVS Caremark Corp et al, U.S. District Court, Eastern District of Pennsylvania, No. 14-00824.
Yahoo
21 minutes ago
- Yahoo
Human Microbiome Market worth $7.09 billion by 2031 with 31.0% CAGR
DELRAY BEACH, Fla., Aug. 20, 2025 /PRNewswire/ -- The global Human Microbiome Market, valued at US$0.91 billion in 2024, stood at US$1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$7.09 billion by the end of the period. The primary drivers behind the expansion of this industry are the technological advancement in microbiome sequencing, the collaborative efforts between the microbiome industry, organizations, and academia for microbiome research, and the increase in the number of startups and SMEs exploring the microbiome niche, and further opportunities such as the increase in demand for personalized medicine and the emergence of synbiotics may help drive the human microbiome market. Download PDF Brochure: Browse in-depth TOC on "Human Microbiome Market" 416 - Tables64 - Figures371 - Pages By type, bacterial consortia transplantation (BCT)/ fecal microbiota transplantation (FMT), live bacteria products, and others segment the human microbiome market. Live bacteria products accounted for the largest share of the human microbiome market in 2024. This category includes probiotics and synbiotics, which are widely used in consumer health supplements and emerging therapeutic applications. The dominance of live bacteria products is driven by strong consumer demand for digestive and immune health solutions, along with increasing clinical validation of specific bacterial strains. These products are often easier to formulate, regulate, and distribute compared to more complex microbiome therapies, allowing for faster commercialization. Additionally, ongoing advancements in encapsulation and delivery technologies have improved bacterial stability and survivability through the gastrointestinal tract, enhancing their effectiveness. The growing focus on personalized nutrition and preventive health has further expanded the adoption of live bacteria products across various age groups and health segments. Fecal microbiota transplantation/biological combination therapies (FMT/BCT) accounted for the second-largest share, supported by approved drugs such as VOWST and Rebyota for recurrent Clostridioides difficile infection. By end users, the human microbiome market is segmented by end users, hospitals & clinics, long-term care facilities, and other end users. Hospitals and clinics accounted for the largest share of the human microbiome market in 2024. This is largely due to their critical role in administering, monitoring, and regulating microbiome-based therapeutics, particularly those targeting infectious and gastrointestinal conditions. Approved products such as VOWST and Rebyota, used to prevent recurrent Clostridioides difficile infection, are typically prescribed and delivered in clinical settings under medical supervision. These facilities provide the necessary infrastructure for managing live microbial therapies, which may require cold-chain storage, specialized handling, and follow-up care. Hospitals and clinics are also key sites for clinical research, including patient enrollment for microbiome-based drug trials and real-world evidence studies. Their involvement enables close monitoring of patient outcomes, adverse events, and long-term therapeutic effects, all of which are essential for the advancement of microbiome science and regulatory approval processes. Moreover, the rising prevalence of chronic conditions linked to microbiome imbalance, such as inflammatory bowel disease and metabolic disorders, has led to increased hospital-based consultations and treatment protocols involving microbiome interventions. The presence of trained healthcare professionals, diagnostic tools, and institutional trust further supports the strong uptake of microbiome products within hospital and clinical environments. By geography, in 2024, North America accounted for the largest share of the human microbiome market. This leading position is supported by a well-established biotechnology ecosystem, strong research and development infrastructure, and the presence of major market players such as Seres Therapeutics, Seed Health, and IFF. The region has seen significant regulatory progress, with the US FDA approving the first microbiome-based drugs, including Rebyota and VOWST, for the prevention of recurrent Clostridioides difficile infection. These approvals have encouraged further investment in microbiome therapeutics and supplements. North America also has high adoption rates for probiotics, prebiotics, and synbiotics, driven by increasing consumer awareness of gut health and preventive wellness. The region supports a growing number of clinical trials and academic collaborations focused on the role of microbiomes in conditions such as gastrointestinal diseases, metabolic disorders, and cancer. Additionally, favorable healthcare spending, innovation funding, and regulatory clarity continue attracting startups and established firms. These combined factors reinforce the dominant position of North America in the global human microbiome market. Request Sample Pages : Some of the leading players in the market include Seres Therapeutics (US), Ferring B.V. (Switzerland), BiomeBank (Australia), Seed Health, Inc. (US), International Flavors & Fragrances Inc. (US), Pendulum (US), Biohm Technologies (US), Actial Farmaceutica Srl (Italy), OptiBiotix Health Plc (UK), resbiotic (US), Infinant Health Inc. (US), BioGaia (Sweden), and ExeGi Pharma (US), among others. Seres Therapeutics (US): Seres Therapeutics is one of the emerging players in the human microbiome market. The company's microbiome therapeutics platform significantly reduces the time typically required to advance therapeutics to the clinic and, ultimately, to the market. The company focuses on R&D to launch advanced products in the market. Its R&D expenses were USD 64.6 million for the year ending December 31, 2024. It specializes in creating oral live biotherapeutic products with defined bacterial consortia intended to modulate the human microbiome. Its lead product, VOWST (formerly SER-109), received FDA approval in April 2023 to prevent recurrent Clostridioides difficile infection. VOWST is the first FDA-approved orally administered microbiome therapeutic. In 2023, Seres Therapeutics implemented organizational changes, including workforce reductions and a narrowed R&D focus. In June 2024, the company entered into an agreement with Nestlé Health Science to transfer full commercialization rights for VOWST. The company continues to pursue clinical development of its remaining programs and maintains collaborations with academic and industry partners. FERRING B.V. (SWITZERLAND) Ferring Pharmaceuticals is a biopharmaceutical company involved in the development of microbiome-based therapeutics. The company operates in multiple therapeutic areas, including reproductive medicine, maternal health, gastroenterology, and urology. Ferring engages in internal research and external partnerships in the microbiome space. It acquired Rebiotix, a company developing live biotherapeutic products targeting the human microbiome. The company developed Rebyota, a fecal microbiota-based therapeutic indicated for preventing recurrent Clostridioides difficile infection. The product received FDA approval in November 2022 and is administered via enema. It has also collaborated with organizations such as Karolinska Institutet, Intralytix, MyBiotics, and PharmaBiome to explore live microbial consortia, bacteriophage-based therapies, and microbiome diagnostics. The company maintains manufacturing and R&D operations in various regions and continues to advance its microbiome programs across therapeutic categories through preclinical and clinical development stages. International Flavors & Fragrances Inc. (US) International Flavors & Fragrances (IFF) operates in the fields of flavor, fragrance, nutrition, and biosciences, with a growing focus on microbiome-based ingredients. The company has developed capabilities in precision fermentation and microbial strain engineering, enabling the industrial-scale production of next-generation probiotics, including strict anaerobes like Akkermansia. These technologies support ingredient development for applications in human and pet health, food, and supplements. IFF's HOWARU brand includes clinically studied probiotic strains such as HN001, HN019, NCFM, Bi-07, and Bl-04. These strains are formulated for specific health outcomes, including immune support, digestive health, stress response, early life development, and healthy aging. HN001 has regulatory recognition in markets like Brazil for reducing eczema risk in infants and pregnant women. IFF offers products such as HOWARU Protect and HOWARU Restore, each targeting different stages of life or health needs. The HOWARU brand includes clinically studied probiotic strains such as HN001, HN019, NCFM, Bi-07, and Bl-04. These strains are formulated for specific health outcomes, including immune support, digestive health, stress response, early life development, and healthy aging. HN001 has regulatory recognition in markets such as Brazil for reducing eczema risk in infants and pregnant women. IFF offers products like HOWARU Protect and HOWARU Restore, each targeting different stages of life or health needs. The microbiome innovation of IFF is supported by ongoing collaborations and a broader portfolio in synthetic biology, enabling the development of functional ingredients across consumer and health product categories. For more information, Inquire Now! Related Reports: Clinical Microbiology Market High Throughput Screening Market Microbiome Sequencing Services Market Rapid Microbiology Testing Market Laboratory Proficiency Testing Market Get access to the latest updates on Human Microbiome Companies and Human Microbiome Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets 登入存取你的投資組合
